Artemis Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-77,601
Closed -$7.56M 287
2020
Q2
$7.56M Sell
77,601
-19,401
-20% -$1.81M 0.1% 192
2020
Q1
$7.86K Sell
97,002
-898
-0.9% -$87.6K 0.01% 145
2019
Q4
$10.6M Sell
97,900
-137,734
-58% -$14.2M 0.13% 157
2019
Q3
$22.8M Buy
235,634
+38,258
+19% +$3.8M 0.31% 107
2019
Q2
$19.1M Buy
197,376
+48,873
+33% +$4.66M 0.23% 131
2019
Q1
$16.4M Sell
148,503
-10,237
-6% -$1.07M 0.19% 147
2018
Q4
$14.6M Buy
158,740
+45,502
+40% +$4.6M 0.19% 140
2018
Q3
$12.5M Buy
+113,238
New +$11.8M 0.14% 167

Other funds holding PRAH

Artemis Investment Management's PRAH Position: Q3 2020 in Review

Artemis Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 77,601 shares — an estimated $7.56M sold.

Artemis Investment Management first reported a position in PRAH in Q3 2018 and held it in 8 quarters. The position peaked at $22.8M in Q3 2019. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Artemis Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Artemis Investment Management sold 77,601 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $7.56M.
  • Artemis Investment Management first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 8 quarters.
  • Artemis Investment Management's PRA Health Sciences, Inc. position peaked at $22.8M in Q3 2019.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Artemis Investment Management's 13F filing for Q3 2020, filed 29 Oct 2020.